Data as of Mar 11
| +0.13 / +27.96%|
The 2 analysts offering 12-month price forecasts for Elite Pharmaceuticals Inc have a median target of 4.25, with a high estimate of 4.50 and a low estimate of 4.00. The median estimate represents a +614.29% increase from the last price of 0.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.